Virus NAT for HIV, HBV, and HCV in Post-Mortal Blood Specimens over 48 h after Death of Infected Patients – First Results

Publisher： Karger

E-ISSN： 1660-3818|39|6|376-380

ISSN： 1660-3796

Source： Transfusion Medicine and Hemotherapy, Vol.39, Iss.6, 2012-11, pp. : 376-380

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Validation of Virus NAT for HIV, HCV, HBV and HAV Using Post-Mortal Blood Samples

By  

Transfusion Medicine and Hemotherapy, Vol. 39, Iss. 6, 2012-11 ,pp. : 381-385

Karger

Access to resources Recommend Favorite

Seroconversion of HIV, HCV, and HBV in Blood Donors in 1996 – Risk of Virus Transmission by Blood Products in Germany

By  

Transfusion Medicine and Hemotherapy, Vol. 25, Iss. 2-3, 1998-06 ,pp. : 82-84

Karger

Access to resources Recommend Favorite

Infections with HIV, HBV, and HCV among Blood Donors in Germany 1998 and 1999

By  

Transfusion Medicine and Hemotherapy, Vol. 29, Iss. 6, 2002-12 ,pp. : 305-307

Karger

Access to resources Recommend Favorite

IP-10 predicts the first phase decline of HCV RNA and overall viral response to therapy in patients co-infected with chronic hepatitis C virus infection and HIV

By Falconer Karolin   Askarieh Galia   Weis Nina   Hellstrand Kristoffer   Alaeus Annette   Lagging Martin    

Scandinavian Journal of Infectious Diseases, Vol. 42, Iss. 11-12, 2010-12 ,pp. : 896-901

Informa Healthcare

Access to resources Recommend Favorite

Hepatitis C Virus-infected, HCV-RNA-negative Patients with Bleeding Disorders - Relationship to Age, HIV and Treatment

By Schulman Sam   Von Sydow Madeleine   Petrini Pia   Fahlstadius Per  

Scandinavian Journal of Infectious Diseases, Vol. 30, Iss. 5, 1998-12 ,pp. : 455-458

Informa Healthcare

Access to resources Recommend Favorite